Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05189782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00162851. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
ClinicalTrials.gov study NCT00504972. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An In-vitro Standardization of B Cell Elispot Assays
ClinicalTrials.gov study NCT01334281. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
ClinicalTrials.gov study NCT02900716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
ClinicalTrials.gov study NCT05275504. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04289220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05961696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02453087. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histolo
ClinicalTrials.gov study NCT01224821. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
ClinicalTrials.gov study NCT03191773. IPD Sharing: NO. Countries: 1. Publications: 0.
NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT07052305. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06253663. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
ClinicalTrials.gov study NCT06393335. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT01144260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL
ClinicalTrials.gov study NCT05379569. IPD Sharing: NO. Countries: 1. Publications: 0.
Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04850495. IPD Sharing: NO. Countries: 1. Publications: 0.
High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma
ClinicalTrials.gov study NCT00965289. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
ClinicalTrials.gov study NCT00561756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label, Phase 2 Study of CD19t-haNK and N-803 in Combination With Rituximab in Participants With Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma.
ClinicalTrials.gov study NCT07125872. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.